Close Menu

NEW YORK -- OpGen announced after the close of the market on Tuesday an 8 percent revenue increase for the fourth quarter of 2019.

For the three months ended Dec. 31, 2019, OpGen's revenues grew to $821,674 from $758,959 million in Q4 2018. The company logged $570,674 in product revenue in Q4, and $250,000 in collaboration revenue.

Fourth quarter R&D expenses fell 42 percent to $1.1 million from $1.9 million, while SG&A costs dropped 19 percent to $1.7 million from $2.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.